Advanced search
Publication Cover
Traffic Injury Prevention Volume 23, 2022 - Issue sup1: Peer-Reviewed Journal for the 66th Annual Scientific Conference of the Association for the Advancement of Automotive Medicine (AAAM)
Submit an article Journal homepage
71
Views
1
CrossRef citations to date
0
Altmetric
Posters from the AAAM 66th Annual Conference

Sensitivity to dose or blood levels of alprazolam in predicting driving impairment

Timothy Browna National Advanced Driving Simulator, University of Iowa, Iowa City, IACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7530-9801View further author information
ORCID Icon,
Rose Schmitta National Advanced Driving Simulator, University of Iowa, Iowa City, IAORCID Iconhttps://orcid.org/0000-0002-8712-975XView further author information
ORCID Icon,
Gary Milavetzb College of Pharmacy, University of Iowa, Iowa City, IAORCID Iconhttps://orcid.org/0000-0002-3822-1285View further author information
ORCID Icon,
Gary Gaffneyc Carver College of Medicine, University of Iowa, Iowa City, IAORCID Iconhttps://orcid.org/0000-0003-1842-7902View further author information
ORCID Icon,
Justin Grodnizkyd Toxicology Section, Iowa Division of Criminal Investigation Criminalistics Laboratory, Ankeny, IAView further author information
,
Jonna Berryd Toxicology Section, Iowa Division of Criminal Investigation Criminalistics Laboratory, Ankeny, IAView further author information
&
Chris Berkae Advanced Brain Monitoring, Carlsbad, CAORCID Iconhttps://orcid.org/0000-0003-1566-2907View further author information
ORCID Icon show all
Pages S231-S232 | Published online: 30 Sep 2022
 
Sample our Engineering & Technology journals, sign in here to start your access, latest two full volumes FREE to you for 14 days
"Sensitivity to dose or blood levels of alprazolam in predicting driving impairment." Traffic Injury Prevention, 23(sup1), pp. S231–S232

Additional information

Funding

The data for this analysis were collected with support from a Small Business Innovative Research Contract HHSN271201100009C from the National Institute on Drug Abuse (NIDA).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.